These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2326027)

  • 1. Visual field defects in patients with insulin-dependent and noninsulin-dependent diabetes.
    Trick GL; Trick LR; Kilo C
    Ophthalmology; 1990 Apr; 97(4):475-82. PubMed ID: 2326027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual fields at different stages of diabetic retinopathy.
    Henricsson M; Heijl A
    Acta Ophthalmol (Copenh); 1994 Oct; 72(5):560-9. PubMed ID: 7887153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduction of retinal light sensitivity in diabetic patients].
    Pahor D
    Klin Monbl Augenheilkd; 2003 Dec; 220(12):868-72. PubMed ID: 14704945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
    Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
    Retina; 1987; 7(3):170-6. PubMed ID: 3423432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial.
    Scott IU; Jackson GR; Quillen DA; Klein R; Liao J; Gardner TW
    JAMA Ophthalmol; 2014 Sep; 132(9):1137-42. PubMed ID: 24969516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-wavelength sensitive visual field loss in patients with clinically significant diabetic macular oedema.
    Hudson C; Flanagan JG; Turner GS; Chen HC; Young LB; McLeod D
    Diabetologia; 1998 Aug; 41(8):918-28. PubMed ID: 9726594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menstrual cycle dependent changes in blue-on-yellow visual field analysis of young diabetic women with severe non-proliferative diabetic retinopathy.
    Apaydin KC; Akar Y; Akar ME; Zorlu GC; Ozer HO
    Clin Exp Ophthalmol; 2004 Jun; 32(3):265-9. PubMed ID: 15180838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual field loss with capillary non-perfusion in preproliferative and early proliferative diabetic retinopathy.
    Chee CK; Flanagan DW
    Br J Ophthalmol; 1993 Nov; 77(11):726-30. PubMed ID: 8280688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional Functional and Structural Evaluation Reveals Neuroretinal Impairment in Early Diabetic Retinopathy.
    Joltikov KA; de Castro VM; Davila JR; Anand R; Khan SM; Farbman N; Jackson GR; Johnson CA; Gardner TW
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO277-BIO290. PubMed ID: 28973314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.
    Boynton GE; Stem MS; Kwark L; Jackson GR; Farsiu S; Gardner TW
    Ophthalmology; 2015 May; 122(5):957-67. PubMed ID: 25601533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated static perimetry as a screening method for evaluation of retinal perfusion in diabetic retinopathy.
    Pahor D
    Int Ophthalmol; 1997-1998; 21(6):305-9. PubMed ID: 9869337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy.
    Han Y; Adams AJ; Bearse MA; Schneck ME
    Arch Ophthalmol; 2004 Dec; 122(12):1809-15. PubMed ID: 15596584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
    Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
    Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and structural change in diabetic eyes. Interim results from an ongoing longitudinal prospective study.
    Hellgren KJ; Bengtsson B; Agardh E
    Acta Ophthalmol; 2013 Nov; 91(7):672-7. PubMed ID: 23025256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and c-peptide levels.
    Kernell A; Ludvigsson J; Finnström K
    Acta Ophthalmol (Copenh); 1990 Aug; 68(4):415-20. PubMed ID: 2220357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SHORT-WAVELENGTH AUTOMATED PERIMETRY IN DIABETIC PATIENTS WITHOUT RETINOPATHY.
    Peprníková S; Skorkovská K; Květon P
    Cesk Slov Oftalmol; 2021; 77(5):248-252. PubMed ID: 34666494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifocal Pupillography Identifies Changes in Visual Sensitivity According to Severity of Diabetic Retinopathy in Type 2 Diabetes.
    Sabeti F; Nolan CJ; James AC; Jenkins A; Maddess T
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4504-13. PubMed ID: 26200488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy.
    Jackson GR; Scott IU; Quillen DA; Walter LE; Gardner TW
    Br J Ophthalmol; 2012 May; 96(5):699-703. PubMed ID: 22174096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy.
    Yoshida A; Kojima M; Ogasawara H; Ishiko S
    Ophthalmology; 1991 Aug; 98(8):1266-71. PubMed ID: 1923365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blue-on-yellow perimetry to evaluate S cone sensitivity in diabetics.
    Nomura R; Terasaki H; Hirose H; Miyake Y
    Ophthalmic Res; 2000; 32(2-3):69-72. PubMed ID: 10754437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.